Mesothelioma patients and their families are particularly vulnerable to ill-meaning “medicine salesmen”, such as the ones portrayed in this special investigation by 60 Minutes. Take a few minutes to watch these videos and please share if you have personally experienced something similar. The only way to stop these scams is to speak up.
Vivace Therapeutics Receives FDA Orphan Drug Designation for VT3989 for Mesothelioma Treatment
Vivace Therapeutics, a company that develops cancer treatments, announced on July 30, 2025, that the U.S. Food and Drug Administration (FDA) has granted its experimental
